Status:

RECRUITING

Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression

Lead Sponsor:

Stanford University

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Depression is a highly prevalent condition characterized by persistent low mood, energy, and activity that can affect one's thoughts, mood, behavior, and sense of well-being. Repetitive transcranial m...

Detailed Description

There is a critical need for more effective treatments for depression, which currently affect 20% of Americans during our lifetimes. Brain stimulation treatments, including repetitive transcranial mag...

Eligibility Criteria

Inclusion

  • Men and women, ages 18 to 65
  • Depression assessed through in-depth Structured Clinical Interview for DMS-5 (SCID-I)
  • PHQ9 \> 10 for disease severity
  • Must comprehend English well to ensure adequate comprehension of the EEG and TMS instructions, and of clinical scales
  • Right-handed
  • No current or history of neurological disorders
  • No seizure disorder or risk of seizures
  • No use of PRN medication within 24 hours of the scheduled study appointment

Exclusion

  • Those with a contraindication for MRIs (e.g. implanted metal)
  • Any unstable medical condition
  • History of head trauma with loss of consciousness
  • History of seizures
  • Neurological or uncontrolled medical disease
  • Active substance abuse
  • Diagnosis of psychotic or bipolar disorder
  • A prior history of ECT or rTMS failure
  • Currently taking medications that substantially reduce seizure threshold (e.g., olanzapine, chlorpromazine, lithium)
  • Currently pregnant or breastfeeding

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05224063

Start Date

January 1 2023

End Date

December 30 2025

Last Update

November 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Stanford, California, United States, 94305

Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression | DecenTrialz